WP
HQL

Woodline Partners’s abrdn Life Sciences Investors HQL Stock Holding History

Woodline Partners’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-52,912
Closed -$716K – 659
2023
Q2 		$716K Hold
52,912
– – 0.01% 512
2023
Q1 		$737K Buy
52,912
+14,328
+37% +$205K 0.01% 496
2022
Q4 		$548K Buy
+38,584
New +$559K 0.01% 594

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
LSC
Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return

Woodline Partners's HQL Position: Q3 2023 in Review

Woodline Partners sold out of abrdn Life Sciences Investors (HQL) in Q3 2023, closing a stake of 52,912 shares — an estimated $716K sold.

Woodline Partners first reported a position in HQL in Q4 2022 and held it in 3 quarters. The position peaked at $737K in Q1 2023. 80 funds tracked by Wall St. Rank hold HQL as of Q3 2023.

  • Woodline Partners reported no remaining abrdn Life Sciences Investors position as of Q3 2023 after selling out during the quarter.
  • Woodline Partners sold 52,912 abrdn Life Sciences Investors shares in Q3 2023, an estimated $716K.
  • Woodline Partners first reported a position in abrdn Life Sciences Investors in Q4 2022 and held it in 3 quarters.
  • Woodline Partners's abrdn Life Sciences Investors position peaked at $737K in Q1 2023.
  • 80 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2023.

Based on Woodline Partners's 13F filing for Q3 2023, filed 14 Nov 2023.